QuidelOrtho Corp (QDEL)
33.00
+0.10
(+0.30%)
USD |
NASDAQ |
Jun 26, 10:01
QuidelOrtho SG&A Expense (TTM): 765.50M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 765.50M |
December 31, 2023 | 763.20M |
September 30, 2023 | 789.20M |
June 30, 2023 | 799.30M |
March 31, 2023 | 738.60M |
December 31, 2022 | 621.00M |
September 30, 2022 | 481.10M |
June 30, 2022 | 339.90M |
March 31, 2022 | 275.70M |
December 31, 2021 | 244.64M |
September 30, 2021 | 229.34M |
June 30, 2021 | 220.17M |
March 31, 2021 | 209.21M |
December 31, 2020 | 200.54M |
September 30, 2020 | 184.44M |
June 30, 2020 | 169.36M |
March 31, 2020 | 165.92M |
December 31, 2019 | 163.87M |
September 30, 2019 | 160.25M |
June 30, 2019 | 158.62M |
March 31, 2019 | 157.87M |
December 31, 2018 | 153.94M |
September 30, 2018 | 150.34M |
June 30, 2018 | 133.38M |
March 31, 2018 | 114.19M |
Date | Value |
---|---|
December 31, 2017 | 96.44M |
September 30, 2017 | 81.80M |
June 30, 2017 | 79.85M |
March 31, 2017 | 78.64M |
December 31, 2016 | 76.91M |
September 30, 2016 | 76.06M |
June 30, 2016 | 75.84M |
March 31, 2016 | 75.42M |
December 31, 2015 | 77.46M |
September 30, 2015 | 76.23M |
June 30, 2015 | 75.51M |
March 31, 2015 | 72.53M |
December 31, 2014 | 68.04M |
September 30, 2014 | 68.00M |
June 30, 2014 | 65.00M |
March 31, 2014 | 62.79M |
December 31, 2013 | 61.61M |
September 30, 2013 | 55.59M |
June 30, 2013 | 53.84M |
March 31, 2013 | 53.63M |
December 31, 2012 | 50.12M |
September 30, 2012 | 50.22M |
June 30, 2012 | 49.36M |
March 31, 2012 | 48.64M |
December 31, 2011 | 48.55M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
158.62M
Minimum
Jun 2019
799.30M
Maximum
Jun 2023
383.99M
Average
236.99M
Median
SG&A Expense (TTM) Benchmarks
Perspective Therapeutics Inc | 19.11M |
Retractable Technologies Inc | 19.28M |
Xtant Medical Holdings Inc | 72.60M |
Asensus Surgical Inc | 34.07M |
Catheter Precision Inc | 9.545M |